Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 3/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14020215 | 0.83 | CYP2C19 (0.37) | MAPTCYP2C19CYP2D6CYP1A2KDM4E | |
| SCHEMBL5179110 | 0.81 | ACHE (0.44) | DNMT1MAPTCYP2C19CYP2D6CYP1A2 | |
| SCHEMBL85960 | 0.81 | ACHE (0.44) | DNMT1MAPTCYP2C19CYP2D6CYP1A2 | |
| SCHEMBL5179117 | 0.81 | ACHE (0.44) | DNMT1MAPTCYP2C19CYP2D6CYP1A2 | |
| SCHEMBL15370914 | 0.76 | MAPT (0.33) | MAPTCYP2C19CYP2D6CYP1A2KDM4E | |
| SCHEMBL14020407 | 0.75 | MAPT (0.44) | MAPTCYP2C19CYP2D6CYP1A2KDM4E | |
| SCHEMBL14490476 | 0.73 | HPGD (0.38) | MAPTCYP2C19CYP2D6CYP1A2KDM4E | |
| SCHEMBL13991935 | 0.72 | MAPT (0.32) | MAPTCYP2C19CYP2D6CYP1A2KDM4E | |
| SCHEMBL12511896 | 0.72 | MAPT (0.44) | MAPTCYP2C19CYP2D6CYP1A2KDM4E | |
| SCHEMBL24186372 | 0.71 | CYP2C19 (0.43) | MAPTCYP2C19CYP2D6CYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100104985-A1 | COMPOUND FOR PHOTORESIST, PHOTORESIST LIQUID, AND ETCHING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20100104985-A1 | COMPOUND FOR PHOTORESIST, PHOTORESIST LIQUID, AND ETCHING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| EP-1688466-B1 | Ink composition, ink jet recording method, printed material, method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORP (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20070009831-A1 | PLANOGRAPHIC PRINTING PLATE MATERIAL AND IMAGE FORMATION METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-11 | — | — | US | disclosed |
| US-20070009831-A1 | PLANOGRAPHIC PRINTING PLATE MATERIAL AND IMAGE FORMATION METHOD | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104985-A1 | COMPOUND FOR PHOTORESIST, PHOTORESIST LIQUID, AND ETCHING METHOD USING THE SAME | PYCR1, STK10, STK4 | DNMT1 207/4885MAPT 264/4885CYP2C19 1717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.